Current status of clinical trials assessing mesenchymal stem cell therapy for graft versus host disease: a systematic review

BACKGROUND: Graft-versus-host disease (GVHD) is a common fatal complication of hematopoietic stem cell transplantation (HSCT), where steroids are used as a treatment option. However, there are currently no second-line treatments for patients that develop steroid-resistance (SR). Mesenchymal stem cel...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Ying, Hao, Jie, Hu, Zheng, Yang, Yong-Guang, Zhou, Qi, Sun, Liguang, Wu, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8895864/
https://www.ncbi.nlm.nih.gov/pubmed/35246235
http://dx.doi.org/10.1186/s13287-022-02751-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8895864/
https://www.ncbi.nlm.nih.gov/pubmed/35246235
http://dx.doi.org/10.1186/s13287-022-02751-0

Ejemplares similares